NCT06706401 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06706401
Title	Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma (Lysari)
Acronym	Lysari
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	Centre Leon Berard
Indications	oropharynx cancer laryngeal squamous cell carcinoma hypopharynx cancer
Therapies	Cisplatin Cetuximab Tretinoin
Age Groups:	adult \| senior
Covered Countries	FRA

Filter rows:

Showing 1 to 2 of 2 entries

Facility	Status	City	State	Zip	Country	Details
Centre Léon Bérard	RECRUITING	Lyon		69008	France	Details
Institut Gustave Roussy	RECRUITING	Villejuif		94805	France	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06706401Clinical Trial Detail